Material and Method: One hundred and fifty healthy women and 150 women diagnosed with vitamin D deficiency were included in our study. Blood samples were collected from all participants to evaluate their 25 hydroxyvitamin D (25(OH)D) levels. Additionally, the Sociodemographic and Clinical Data Form, the Wender Utah Rating Scale-Short Form (WURS-25) and the Turkish version of the Adult ADHD Self-Report Scale (ASRS-v1.1) were administered.

Results: Participants with vitamin D deficiency scored higher on the Turkish version of the ASRS-v1.1 and WURS-25. Turkish version of the ASRS-v1.1 was positively correlated with WURS-25 and negatively correlated with vitamin D levels. Patients with WURS-25 scores of 36 and above were younger, more likely to be single, lived in urban areas, and had lower vitamin D levels and scored higher on the ASRS-v1.1. We analyzed the optimal cutoff point of vitamin D level, predicting a higher WURS-25 score. Vitamin D level was found to be significant for the WURS-25 score of 36 and above with a cutoff point of ≤24 (Area under curve:0.702, p =<0.001).

Conclusion: Attention-Deficit and Hyperactivity Disorder symptoms are commen among women with vitamin D deficiency during both childhood and adulthood. Early diagnosis and treatment of ADHD may be beneficial for patients with vitamin D deficiency.

Vitamin D receptors are present in many tissues, and 1-α-hydroxylase-the enzyme responsible for activating vitamin D-is found in the brain, particularly in the prefrontal cortex, hippocampus, and hypothalamus. Moreover, the active form of vitamin D can cross the blood-brain barrier, suggesting its potential involvement in cerebral and cognitive functions^5,6. In addition to its effects on memory function and cognitive decline, vitamin D deficiency has been linked to neuropsychiatric diseases^7,8. Almukbil et al. reported that academic performance is poorer in individuals with vitamin D deficiency and suggested that treating this deficiency may support mental health and psychological well-being⁹.

Adult attention-deficit and hyperactivity disorder (ADHD) is a neurodevelopmental disorder that begins in childhood and persists into adolescence and adult-hood, characterized by symptoms of inattention, emotional dysregulation, impulsivity, and disinhibition^10,11. The prevalence of ADHD in the general population is estimated to range between 1% and 6% ¹². Dopamine has been reported to play a crucial role in the pathogenesis of ADHD due to its regulatory effects on executive functions and psychomotor activity¹³. Vitamin D enhances dopamine synthesis and release, thereby regulating the differentiation and functions of dopaminergic neurons¹⁴. It may directly affect dopaminergic signaling by regulating the gene expression of tyrosine hydroxylase, an enzyme involved in dopamine biosynthesis¹⁵. Furthermore, vitamin D may influence synaptic plasticity and neuronal survival by modulating brain-derived neurotrophic factor (BDNF) levels¹⁶. BDNF is an essential neurotrophin that regulates synaptic function in brain regions associated with cognitive control. Studies have suggested that low vitamin D levels suppress BDNF expression, which may contribute to the cognitive dysfunctions observed in ADHD^16,17. Additionally, vitamin D affects other neurotransmitter pathways, such as the glutamatergic and GABAergic systems, and may have broad effects on multiple biological substrates implicated in neurodevelopmental disorders¹⁸. A potential association between vitamin D deficiency and ADHD symptoms has been suggested¹⁹. Meta-analyses have shown that serum 25(OH)D concentrations are lower in pediatric patients with ADHD compared to healthy controls²⁰. Vitamin D supplementation has also been shown to reduce ADHD symptoms²¹.

Studies have indicated that vitamin D deficiency is more prevalent in women than in men, particularly among individuals whose clothing limits sunlight exposure^22,23. To the best of our knowledge, no studies have examined the relationship between vitamin D deficiency and ADHD symptoms in adults or the clinical variables influencing this relationship. In this study, we aimed to investigate adult ADHD symptoms in women with vitamin D deficiency and compare them with healthy controls without vitamin D deficiency. Our study differs from previous research in that we focused specifically on adult women and utilized the WURS-25 to assess childhood ADHD symptoms. By doing so, we aimed to evaluate whether psychiatric scales combined with vitamin D levels can aid in identifying adult patients with ADHD who might otherwise be overlooked, in contrast to previous studies with smaller sample sizes.

The Scales Used in the Study:
Sociodemographic and Clinical Data Form: Sociodemographic and Clinical Data Form: This semistructured form, created by the researchers, gathers important sociodemographic information from respondents, including age, economic status, and marital status. It also collects clinical data, such as psychiatric disease history and smoking history.

Turkish Version of the Adult ADHD Self-Report Scale (ASRS-v1.1): This scale^24, developed by the World Health Organization to screen for mental disorders, measures the severity of ADHD symptoms in adulthood. The questions in this scale aim to identify a person's mental symptoms over the past six months. The scale was adapted to Turkish, and its validity and reliability were demonstrated²⁵.

Wender Utah Rating Scale - Short Form (WURS-25):
This scale was designed to assess the presence and severity of childhood ADHD signs and symptoms in adults²⁶. It's important to note that the scale evaluates adults' experiences during childhood and cannot be used for diagnosing adults based solely on the score. The scale has been adapted into Turkish, and its validity and reliability have been confirmed²⁷. When a score of 36 or above is used as the cutoff point, the scale can accurately classify 82.5% of adults with ADHD, 90.8% of the control group (specificity), 66% of individuals with depression, and 64.3% of those with bipolar disorder.

Statistical analysis:
Statistical analyses were conducted using version 14.0 of the Statistical Package for Social Sciences (SPSS). Continuous variables were assessed for normality using the Kolmogorov-Smirnov test and histograms. Normally distributed parameters were compared using Student's t-test, while parameters that did not follow a normal distribution were analyzed using the Mann-Whitney U test. Categorical variables were compared using either the Chi-square test or Fisher's exact test, depending on the situation.

The strength of the relationship between two variables was evaluated with Spearman's or Pearson's correlation coefficient. A statistical difference was considered significant when the p-value was less than 0.05. To assess the ability of vitamin D levels to predict a higher score on the Wender Utah Rating Scale, receiver operating characteristic (ROC) analysis was performed. The accuracy of the tests was measured by the area under the ROC curve (AUC). An AUC close to 1 indicates a perfect diagnostic test, whereas an AUC of 0.5 suggests the test is not useful.

Click Here to Zoom

Table 1: Baseline characteristics of participants.

As shown in the table, both age and age range were similar between the two groups. No significant differences were found between the study group and the control group in terms of marital status, alcohol consumption, smoking, history of psychological disorder, family history of psychological disorder, and suicide attempt. However, participants with vitamin D deficiency had higher scores on the Turkish version of the Adult ADHD Self-Report Scale and the WURS-25 scores, as well as higher educational and economic status, compared to those without vitamin D deficiency.

The relationship between age, vitamin D level, the WURS-25 score, and the Turkish version of the ASRS-v1.1 score is presented in Table 2.

Click Here to Zoom

Table 2: Relationship between Turkish version of the adult adhd self-report scale (ASRS-V1.1) and other numerical parameters.

The Turkish version of the ASRS-v1.1 showed a positive correlation with the WURS-25 and a negative correlation with vitamin D levels. The participants were categorized into two groups: those with a score of 36 and above on the WURS-25 and those with a score below 36. Participants with Wender Utah Rating Scale scores of 36 and above were younger, more likely to be single, lived in urban areas, had lower vitamin D levels, and scored higher on the Turkish version of the ASRS-v1.1, as summarized in Table 3.

Click Here to Zoom

Table 3: Relationship between wender utah rating scale score and other numerical parameters.

We analyzed the optimal cutoff point of vitamin D level for predicting a higher Wender Utah Rating Scale score. Vitamin D levels were found to be significant for the WURS-25 score of 36 and above, with a cutoff point of ≤24 (Area under the curve: 0.702, p ≤ 0.001) (Figure 1).

Click Here to Zoom

Figure 1: Receiver operating characteristic curve for vitamin D level.

Symptoms of adult attention-deficit/hyperactivity disorder (ADHD) begin in childhood and often continue into adulthood. However, the factors involved in the etiopathogenesis of ADHD remain unclear. Villagomez et al. reported that children diagnosed with ADHD had lower levels of vitamin D, magnesium, iron, and zinc. Vitamin D deficiency has detrimental effects on cognitive and behavioral functions, and insufficient vitamin D levels can increase the risk of cognitive dysfunction and structural defects in the brain. Naeini et al. demonstrated that children diagnosed with ADHD between the ages of 6 and 13 years exhibited vitamin D deficiency. Additionally, those diagnosed with ADHD often have deficiencies in vitamin D and magnesium; supplementation of these nutrients has been shown to reduce ADHD symptoms.

In a study conducted on 133 patients with ADHD, Landaas et al. associated low levels of vitamins B2, B6, and B9 with ADHD diagnosis, noting that deficiencies in B2 and B6 correlated with symptom severity. Another study found that the prevalence of adult ADHD in female patients with iron deficiency anemia was higher than in the general population. A recent randomized controlled trial indicated that ADHD symptoms significantly decreased in adult patients who took vitamin-mineral supplements.

In this study, the scores from the ASRS-v1.1 and WURS-25, tools used to measure and evaluate adult ADHD symptoms, were statistically significantly higher in women with vitamin D deficiency compared to healthy individuals in the control group. It was also found that lower levels of vitamin D were associated with higher ADHD scale scores. This finding suggests that vitamin D deficiency may contribute to increased severity of adult ADHD symptoms, consistent with other research examining the relationship between vitamin D deficiency and ADHD.

Furthermore, patients with a WURS-25 score of 36 and above had lower vitamin D levels and higher adult ADHD scores. The study has some limitations, such as its crosssectional design, small sample size, and being conducted at a single center, which may introduce selection bias. Potential confounding factors, including lifestyle elements (e.g., diet, exercise, sun exposure), other nutrient deficiencies, and comorbidities, may have also influenced the results.

Despite these limitations, this study contributes to the literature by exploring both childhood and adult ADHD in individuals with vitamin D deficiency. Strengths include the inclusion of newly diagnosed patients with vitamin D deficiency and the lack of gender differences affecting the findings, due to the sample consisting solely of females.

Vitamin D deficiency may exacerbate symptom severity by negatively impacting dopamine synthesis and neurotrophic factors. From a clinical standpoint, routinely screening vitamin D levels in women who exhibit symptoms such as attention deficits and executive dysfunction could help identify underlying biological factors.

Early diagnosis and treatment of ADHD are crucial, as it significantly influences individuals in their personal, social, and professional lives. The relationship between vitamin D deficiency and ADHD supports the development of diagnostic algorithms tailored for females, especially considering the genderspecific neurobiological responses and hormonal differences observed in women. However, these findings should be validated through prospective, controlled studies before being integrated into clinical practice.

We believe our study will pave the way for further research examining the relationship between vitamin D deficiency and ADHD. In the future, we recommend conducting longitudinal studies to explore the causal relationship between vitamin D deficiency and ADHD, as well as intervention studies to evaluate the effectiveness of vitamin D supplementation in improving ADHD symptoms.

1) Knuth MM Vitamin d Deficiency: A Precursor to Stunted Growth and Metabolic Dysregulation. North Carolina State University 2020.

2) Amrein K, Scherkl M, Hoffmann M et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nut 2020; 74: 1498-513.

3) Khammissa RAG, Fourie J, Motswaledi MH, Ballyram R, Lemmer J, Feller L. The Biological Activities of Vitamin D and Its Receptor in Relation to Calcium and Bone Homeostasis, Cancer, Immune and Cardiovascular Systems, Skin Biology, and Oral Health. Biomed Res Int 2018; 2018: 9276380.

4) Voiculescu VM, Nelson Twakor A, Jerpelea N, Pantea Stoian A. Vitamin D: Beyond Traditional Roles-Insights into Its Biochemical Pathways and Physiological Impacts. Nutrients 2025; 17: 803.

5) Khatoon R. Unlocking the Potential of Vitamin D: A Comprehensive Exploration of Its Role in Neurological Health and Diseases. Biology (Basel) 2025; 14: 280.

6) Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum S. The Role of Vitamin D in Brain Health: A Mini Literature Review. Cureus 2018; 10: 2960.

7) Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 2013; 34: 47-64.

8) Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007; 460: 202-5.

9) Almuqbil M, Almadani ME, Albraiki SA et al. Impact of Vitamin D Deficiency on Mental Health in University Students: A Cross-Sectional Study. Healthcare (Basel) 2023; 11: 2097.

10) Hesslinger B, van Elst LT, Nyberg E et al. Psychotherapy of attention deficit hyperactivity disorder in adults: A pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 2002; 252: 177-84.

11) Oerbeck B, Overgaard K, Pripp AH, Aase H, Reichborn-Kjennerud T, Zeiner P. Adult ADHD symptoms and satisfaction with life: Does age and sex matter? J Atten Disord 2019; 23: 3-11.

12) Kessler RC, Adler L, Barkley R et al. The preva-lence and correlates of adult ADHD in the United States: results from the National Comorbidity Sur-vey Replication. Am J Psychiatry 2006; 163: 716-23.

13) Blum K, Chen AL, Braverman ER et al. Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 2008; 4: 893-918.

14) Pertile RAN, Brigden R, Raman V, Cui X, Du Z, Eyles D. Vitamin D: A potent regulator of dopaminergic neuron differentiation and function. J Neurochem 2023; 166: 779-89.

15) Sailike B, Onzhanova Z, Akbay B et al. Vitamin D in central nervous system: implications for neu-rological disorders. Int J Mol Sci 2024; 25: 7809.

16) Alqudah M, Khanfar M, Alfaqih MA et al. Correlation between vitamin D and serum brain derived neurotropic factor levels in type 2 diabetes mellitus patients. Biomed Rep 2022; 16: 54.

17) Miranda M, Morici JF, Zanoni MB et al. Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Front Cell Neurosci 2019; 13: 363.

18) Ye X, Zhou Q, Ren P, et al. The Synaptic and Circuit Functions of Vitamin D in Neurodevelopment Disorders. Neuropsychiatr Dis Treat 2023; 19: 1515-30.

19) Fasihpour B, Moayeri H, Shariat M, Keihanidoust Z, Effatpanah M, Khedmat L. Vitamin D defici-ency in schoolage Iranian children with attention-deficit/hyperactivity disorder (ADHD) symptoms: a critical comparison with healthy controls. Child Neuropsychol 2020; 26: 460-74.

20) Khoshbakht Y, Bidaki R, Salehi-Abargouei A. Vitamin D Status and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Observational Studies. Adv Nutr 2018; 1: 9-20.

21) Gan J, Galer P, Ma D, Chen C, Xiong T. The Effect of Vitamin D Supplementation on Attention-Deficit/Hyperactivity Disorder: A Systematic Re-view and Meta-Analysis of Randomized Controlled Trials. J Child Adolesc Psychopharmacol 2019; 29: 670-87.

22) Hekimsoy Z, Dinç G, Kafesçiler S et al. Vitamin D status among adults in the Aegean region of Turkey. BMC Public Health 2010; 10: 782.

23) Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007; 103: 620-5.

24) Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004; 13: 93-121.

25) Dogan S, Öncü B, Varol-Saraçoglu G, Küçükgöncü S. Eriskin Dikkat Eksikligi Hiperaktivite Bozuklugu Kendi Bildirim Ölçegi (ASRS-v1. 1): Türkçe formunun geçerlilik ve güvenilirligi/Validity and reliability of the Turkish version of the Adult ADHD Self-Report Scale (ASRS-v1. 1). Anadolu Psikiyatri Derg 2009; 10: 77.

26) Ward MF, Wender PH, Reimherr FW. The Wen-der Utah Rating Scale: An Aid in the Retrospective Diagnosis of Childhood Attention-Deficit Hy-peractivity Disorder. Am J Psychiatry 1993; 150: 885-90.

27) Oncu B, Olmez Ş, Şenturk V. Wender-Utah Derecelendirme Olceği’nin Turkce formunun erişkin Dikkat Eksikliği Hiperaktivite Bozukluğu’nda geçerlik ve guvenirlik calışması. Turk Psikiyatri Derg 2005; 16: 252-9.

28) Faraone SV, Biederman J, Spencer T et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000; 48: 9-20.

29) Thapar A, Cooper M, Jefferies R, Stergiakouli E. What causes attention deficit hyperactivity disorder? Arch Dis Child 2012; 97: 260-5.

30) Villagomez A, Ramtekkar U. Iron, magnesium, vitamin D, and zinc deficiencies in children presenting with symptoms of attention-deficit/hyperactivity disorder. Children 2014; 1: 261-79.

31) Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 2015; 29: 2207-22.

32) Naeini AA, Fasihi F, Najafi M, Ghazvini MR, Hasanzadeh A. The effects of vitamin D supplementation on ADHD (Attention Deficit Hyperacti-vity Disorder) in 6-13 year-old students: A randomized, double-blind, placebo-controlled study. Eur J Integr Med 2019; 25: 28-33.

33) Landaas ET, Aarsland TIM, Ulvik A et al. Vitamin levels in adults with ADHD. BJPsych Open 2016; 2: 377-84.

34) Demirci K, Baş FY, Arslan B, Salman Z, Akpinar A, Demirdaş A. The investigation of symptoms and diagnoses of adult-attention deficit/hyperactivity disorder in women with iron deficiency anemia. Arch of Neuropsychiatr 2017; 54: 72.

35) RuckJJ, Frampton CM, Gorman B, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 2014; 204: 306-15.